Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the efficacy of Ragweed-SPIRE 12 months after the initial dose.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Circassia Limited
Collaborators
NCT04435990 · Rhinitis, Allergic, Rhinoconjunctivitis, and more
NCT06778213 · Allergic Rhinoconjunctivitis
NCT07427576 · Mite Allergy, Dermatophagoides Farinae Allergy, and more
NCT06922448 · Allergic Rhinoconjunctivitis
NCT04502966 · Allergic Rhinoconjunctivitis, Grass Pollen Allergy
Kanata Allergy Services
Kanata, Ontario
Inflamax Research
Mississauga, Ontario
Windsor Allergy Asthma Associates
Windsor, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions